Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols

zur Hausen, 1974, Attempts to detect virus-specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus, Int. J. Cancer, 13, 650, 10.1002/ijc.2910130509 Narisawa-Saito, 2007, Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins, Cancer Sci., 98, 1505, 10.1111/j.1349-7006.2007.00546.x Bharti, 2009, Anti-human papillomavirus therapeutics: facts & future, Indian J. Med. Res., 130, 296 Baak, 2006, Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers, J. Clin. Pathol., 59, 1017, 10.1136/jcp.2005.027839 Hamid, 2009, The regulation of cell proliferation by the papillomavirus early proteins, Cell Mol. Life Sci., 66, 1700, 10.1007/s00018-009-8631-7 Moody, 2010, Human papillomavirus oncoproteins: pathways to transformation, Nat. Rev. Cancer, 10, 550, 10.1038/nrc2886 Jayshree, 2009, Cell intrinsic & extrinsic factors in cervical carcinogenesis, Indian J. Med. Res., 130, 286 Scheffner, 1993, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53, Cell, 75, 495, 10.1016/0092-8674(93)90384-3 Massimi, 2008, HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background, Oncogene, 27, 1800, 10.1038/sj.onc.1210810 Vogt, 2006, Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein, Oncogene, 25, 4009, 10.1038/sj.onc.1209429 Thomas, 1998, Inhibition of Bak-induced apoptosis by HPV-18 E6, Oncogene, 17, 2943, 10.1038/sj.onc.1202223 James, 2006, Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner, J. Virol., 80, 5301, 10.1128/JVI.01942-05 Yuan, 2005, Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis, Oncogene, 24, 5069, 10.1038/sj.onc.1208691 Dyson, 1998, The regulation of E2F by pRB-family proteins, Genes Dev., 12, 2245, 10.1101/gad.12.15.2245 Giarre, 2001, Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest, J. Virol., 75, 4705, 10.1128/JVI.75.10.4705-4712.2001 Balan, 2011, Immunohistochemical evaluation of COX-2 expression in HPV-positive cervical squamous intraepithelial lesions, Rom. J. Morphol. Embryol., 52, 39 Subbaramaiah, 2007, Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange, Cancer Res., 67, 3976, 10.1158/0008-5472.CAN-06-4273 Kim, 2009, Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein, Carcinogenesis, 30, 753, 10.1093/carcin/bgp066 Sudarshan, 2010, The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes, Biochem. Biophys. Res. Commun., 399, 617, 10.1016/j.bbrc.2010.07.125 Moktar, 2011, Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells, Int. J. Oncol., 39, 941 Beevi, 2007, Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma, Clin. Chim. Acta, 375, 119, 10.1016/j.cca.2006.06.028 Finkel, 2003, Oxidant signals and oxidative stress, Curr. Opin. Cell Biol., 15, 247, 10.1016/S0955-0674(03)00002-4 Darr, 1994, Free radicals in cutaneous biology, J. Invest. Dermatol., 102, 671, 10.1111/1523-1747.ep12374036 Jurkiewicz, 1994, Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study, Photochem. Photobiol., 59, 1, 10.1111/j.1751-1097.1994.tb04993.x Beckman, 1997, Oxidative decay of DNA, J. Biol. Chem., 272, 19633, 10.1074/jbc.272.32.19633 Cadet, 1999, Hydroxyl radicals and DNA base damage, Mutat. Res., 424, 9, 10.1016/S0027-5107(99)00004-4 Vilenchik, 2003, Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer, Proc. Natl. Acad. Sci. U. S. A., 100, 12871, 10.1073/pnas.2135498100 Mates, 1999, Antioxidant enzymes and human diseases, Clin. Biochem., 32, 595, 10.1016/S0009-9120(99)00075-2 Maynard, 2009, Base excision repair of oxidative DNA damage and association with cancer and aging, Carcinogenesis, 30, 2, 10.1093/carcin/bgn250 Storz, 2005, Reactive oxygen species in tumor progression, Front. Biosci., 10, 1881, 10.2741/1667 Burdon, 1995, Superoxide and hydrogen peroxide in relation to mammalian cell proliferation, Free Radic. Biol. Med., 18, 775, 10.1016/0891-5849(94)00198-S Toyokuni, 1995, Persistent oxidative stress in cancer, FEBS Lett., 358, 1, 10.1016/0014-5793(94)01368-B Kryston, 2011, Role of oxidative stress and DNA damage in human carcinogenesis, Mutat. Res., 711, 193, 10.1016/j.mrfmmm.2010.12.016 Liou, 2010, Reactive oxygen species in cancer, Free. Radic. Res., 44, 479, 10.3109/10715761003667554 Sgambato, 2004, Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis, Gynecol. Oncol., 92, 776, 10.1016/j.ygyno.2003.12.008 Perluigi, 2009, Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation, J. Cell. Mol. Med., 13, 1809, 10.1111/j.1582-4934.2008.00465.x Cairns, 2011, Regulation of cancer cell metabolism, Nat. Rev. Cancer, 11, 85, 10.1038/nrc2981 De Marco, 2007, UVB irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells, Virus Res., 130, 249, 10.1016/j.virusres.2007.06.018 Looi, 2008, Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix, Eur. J. Cancer Prev., 17, 555, 10.1097/CEJ.0b013e328305a10b Kim, 2003, Changes in lipid peroxidation and antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer, Nutr. Cancer, 47, 126, 10.1207/s15327914nc4702_3 Goncalves, 2005, Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women, Clin. Biochem., 38, 1071, 10.1016/j.clinbiochem.2005.09.008 Thomasset, 2007, Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties, Int. J. Cancer, 120, 451, 10.1002/ijc.22419 D'Archivio, 2008, Modulatory effects of polyphenols on apoptosis induction: relevance for cancer prevention, Int. J. Mol. Sci., 9, 213, 10.3390/ijms9030213 Forman, 2002, Redox signaling, Mol. Cell. Biochem., 234–235, 49, 10.1023/A:1015913229650 Nair, 2007, Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells, Acta Pharmacol. Sin., 28, 459, 10.1111/j.1745-7254.2007.00549.x Gopalakrishnan, 2008, Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells, Food Chem. Toxicol., 46, 1257, 10.1016/j.fct.2007.09.082 Hansen, 2004, Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1, Toxicol. Sci., 82, 308, 10.1093/toxsci/kfh231 Karin, 1995, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem., 270, 16483, 10.1074/jbc.270.28.16483 Matthews, 1993, Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B, Nucleic Acids Res., 21, 1727, 10.1093/nar/21.8.1727 Hansen, 2006, Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling, Annu. Rev. Pharmacol. Toxicol., 46, 215, 10.1146/annurev.pharmtox.46.120604.141122 Sporn, 1991, Carcinogenesis and cancer: different perspectives on the same disease, Cancer Res., 51, 6215 Hu, 2006, Altered Bcl-2 and Bax expression is associated with cultured first trimester human cytotrophoblasts apoptosis induced by hypoxia, Life Sci., 79, 351, 10.1016/j.lfs.2006.01.011 Jeong, 2005, Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells, J. Biochem. Mol. Biol., 38, 167, 10.5483/BMBRep.2005.38.2.167 Nair, 2006, Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice, Pharm. Res., 23, 2621, 10.1007/s11095-006-9099-x Shen, 2005, Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents, Antioxid. Redox Signal., 7, 1648, 10.1089/ars.2005.7.1648 Shen, 2006, Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin, Mol. Cancer Ther., 5, 39, 10.1158/1535-7163.MCT-05-0293 Siegel, 2010, Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia, Gynecol. Oncol., 118, 289, 10.1016/j.ygyno.2010.05.022 Tomita, 2010, Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women, Int. J. Cancer, 126, 703, 10.1002/ijc.24793 Goel, 2010, Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs, Nutr. Cancer, 62, 919, 10.1080/01635581.2010.509835 Zoberi, 2002, Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines, Cancer Lett., 175, 165, 10.1016/S0304-3835(01)00719-4 Brouet, 1995, Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages, Biochem. Biophys. Res. Commun., 206, 533, 10.1006/bbrc.1995.1076 Sreejayan, 1997, Nitric oxide scavenging bCBEy curcuminoids, J. Pharm. Pharmacol., 49, 105, 10.1111/j.2042-7158.1997.tb06761.x Srivastava, 1985, Anti-thrombotic effect of curcumin, Thromb. Res., 40, 413, 10.1016/0049-3848(85)90276-2 Venkatesan, 1998, Curcumin attenuation of acute adriamycin myocardial toxicity in rats, Br. J. Pharmacol., 124, 425, 10.1038/sj.bjp.0701877 Deodhar, 1980, Preliminary study on antirheumatic activity of curcumin (diferuloyl methane), Indian J. Med. Res., 71, 632 Chan, 2005, Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania, Parasitol. Res., 96, 49, 10.1007/s00436-005-1323-9 Khafif, 2009, Curcumin: a potential radio-enhancer in head and neck cancer, Laryngoscope, 119, 2019, 10.1002/lary.20582 Lin, 2001, Mechanisms of cancer chemoprevention by curcumin, Proc. Natl. Sci. Counc. Repub. China B, 25, 59 Kang, 2004, Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells, J. Pharmacol. Sci., 94, 325, 10.1254/jphs.94.325 Han, 2002, Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells, J. Biochem. Mol. Biol., 35, 337, 10.5483/BMBRep.2002.35.3.337 Liu, 1993, Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells, Carcinogenesis, 14, 857, 10.1093/carcin/14.5.857 Plummer, 1999, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980 Plummer, 2001, Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents, Cancer Epidemiol. Biomarkers Prev., 10, 1295 Lin, 1998, Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion, Oncology, 55, 349, 10.1159/000011876 Mohan, 2000, Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B, J. Biol. Chem., 275, 10405, 10.1074/jbc.275.14.10405 Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer. Res., 21, 2895 Rao, 1995, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound, Cancer Res., 55, 259 Kawamori, 1999, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer, Cancer Res., 59, 597 Venkatraman, 2005, Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis, Mol. Carcinog., 44, 51, 10.1002/mc.20116 Bava, 2005, Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization, J. Biol. Chem., 280, 6301, 10.1074/jbc.M410647200 Prusty, 2005, Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin, Int. J. Cancer, 113, 951, 10.1002/ijc.20668 Divya, 2006, Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis, Mol. Carcinog., 45, 320, 10.1002/mc.20170 Singh, 2009, Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells, Mol. Cell. Biochem., 325, 107, 10.1007/s11010-009-0025-5 Singh, 2011, Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells, Mol. Cell. Biochem., 347, 1, 10.1007/s11010-010-0606-3 Madden, 2009, Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer, Prostaglandins Leukot. Essent. Fatty Acids, 80, 9, 10.1016/j.plefa.2008.10.003 Maher, 2011, Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7, Mol. Carcinog., 50, 47, 10.1002/mc.20695 Javvadi, 2008, The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway, Mol. Pharmacol., 73, 1491, 10.1124/mol.107.043554 Javvadi, 2010, Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells, Cancer Res., 70, 1941, 10.1158/0008-5472.CAN-09-3025 Sreekanth, 2011, Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer, Oncogene, 30, 3139, 10.1038/onc.2011.23 Bava, 2011, Akt is upstream and MAPKs are downstream of NF-kappaB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism, Int. J. Biochem. Cell Biol., 43, 331, 10.1016/j.biocel.2010.09.011 Sultana, 2005, Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity, J. Neurochem., 92, 749, 10.1111/j.1471-4159.2004.02899.x Mohmmad Abdul, 2005, Protection against amyloid beta-peptide (1–42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease, Biochim. Biophys. Acta, 1741, 140, 10.1016/j.bbadis.2004.12.002 Joshi, 2006, Neurochem. Int., 48, 318, 10.1016/j.neuint.2005.11.006 Perluigi, 2006, In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1–42-induced oxidative stress, J. Neurosci. Res., 84, 418, 10.1002/jnr.20879 Di Domenico, 2009, Protective effect of ferulic acid ethyl ester against oxidative stress mediated by UVB irradiation in human epidermal melanocytes, Free. Radic. Res., 43, 365, 10.1080/10715760902777329 Jayaprakasam, 2006, Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation, J. Agric. Food Chem., 54, 5375, 10.1021/jf060899p Zheng, 2008, Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu (II) ions: mechanism and structure–activity relationship, Food Chem. Toxicol., 46, 149, 10.1016/j.fct.2007.07.010 Karthikeyan, 2011, Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro, Toxicol. In Vitro, 10.1016/j.tiv.2011.05.007 Yu, 1995, Green-tea consumption and risk of stomach cancer: a population-based case–control study in Shanghai, China, Cancer Causes Control, 6, 532, 10.1007/BF00054162 Ji, 1997, Green tea consumption and the risk of pancreatic and colorectal cancers, Int. J. Cancer, 70, 255, 10.1002/(SICI)1097-0215(19970127)70:3<255::AID-IJC1>3.0.CO;2-W Graham, 1992, Green tea composition, consumption, and polyphenol chemistry, Prev. Med., 21, 334, 10.1016/0091-7435(92)90041-F Horie, 2005, Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells, Biol. Pharm. Bull., 28, 574, 10.1248/bpb.28.574 Nihal, 2005, Anti-proliferative and proapoptotic effects of (−)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma, Int. J. Cancer, 114, 513, 10.1002/ijc.20785 Baliga, 2005, Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems, Clin. Cancer Res., 11, 1918, 10.1158/1078-0432.CCR-04-1976 Kondo, 2002, Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding, Cancer Lett., 180, 139, 10.1016/S0304-3835(02)00007-1 Fassina, 2004, Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate, Clin. Cancer Res., 10, 4865, 10.1158/1078-0432.CCR-03-0672 Qanungo, 2005, Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells, Carcinogenesis, 26, 958, 10.1093/carcin/bgi040 Ahmad, 2000, Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate, Biochem. Biophys. Res. Commun., 275, 328, 10.1006/bbrc.2000.3297 Liang, 1999, Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)-epigallocatechin-3-gallate, J. Cell. Biochem., 75, 1, 10.1002/(SICI)1097-4644(19991001)75:1<1::AID-JCB1>3.0.CO;2-N Ahmad, 1997, Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells, J. Natl. Cancer Inst., 89, 1881, 10.1093/jnci/89.24.1881 Chen, 1998, Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts, Cancer Lett., 129, 173, 10.1016/S0304-3835(98)00108-6 Nanjo, 1993, Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets, Biol. Pharm. Bull., 16, 1156, 10.1248/bpb.16.1156 Nakagawa, 2002, Direct scavenging of nitric oxide and superoxide by green tea, Food Chem. Toxicol., 40, 1745, 10.1016/S0278-6915(02)00169-2 Haenen, 1997, Peroxynitrite scavenging by flavonoids, Biochem. Biophys. Res. Commun., 236, 591, 10.1006/bbrc.1997.7016 Scott, 1993, Evaluation of the antioxidant actions of ferulic acid and catechins, Free. Radic. Res. Commun., 19, 241, 10.3109/10715769309056512 Sah, 2004, Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases, J. Biol. Chem., 279, 12755, 10.1074/jbc.M312333200 Khan, 2006, Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate, Cancer Res., 66, 2500, 10.1158/0008-5472.CAN-05-3636 Na, 2006, Intracellular signaling network as a prime chemopreventive target of (−)-epigallocatechin gallate, Mol. Nutr. Food Res., 50, 152, 10.1002/mnfr.200500154 Ahn, 2003, A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression, DNA Cell Biol., 22, 217, 10.1089/104454903321655846 Asif Siddiqui, 2011, Apoptotic effect of green tea polyphenol (EGCG) on cervical carcinoma cells, Diagn. Cytopathol., 39, 482, 10.1002/dc.21434 Kuhn, 2004, Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor, Biochim. Biophys. Acta, 1682, 1, 10.1016/j.bbalip.2003.12.006 Noguchi, 2006, Inhibitory effect of the tea polyphenol, (−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines, Cancer Lett., 234, 135, 10.1016/j.canlet.2005.03.053 Yokoyama, 2004, The tea polyphenol, (−)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines, Gynecol. Oncol., 92, 197, 10.1016/j.ygyno.2003.09.023 Zhang, 2006, Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells, Mol. Cancer Ther., 5, 1227, 10.1158/1535-7163.MCT-05-0490 Tudoran, 2011, Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumor cells, J. Cell. Mol. Med. Li, 2007, Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)-epigallocatechin-3-gallate regulates cell transformation, Cancer Epidemiol. Biomarkers Prev., 16, 598, 10.1158/1055-9965.EPI-06-0892 Jacob, 2007, The green tea component EGCG inhibits RNA polymerase III transcription, Biochem. Biophys. Res. Commun., 360, 778, 10.1016/j.bbrc.2007.06.114 Qiao, 2009, Cell growth inhibition and gene expression regulation by (−)-epigallocatechin-3-gallate in human cervical cancer cells, Arch. Pharm. Res., 32, 1309, 10.1007/s12272-009-1917-3 Zou, 2010, Green tea compound in chemoprevention of cervical cancer, Int. J. Gynecol. Cancer, 20, 617, 10.1111/IGC.0b013e3181c7ca5c Bonfili, 2011, Identification of an EGCG oxidation derivative with proteasome modulatory activity, Biochimie, 93, 931, 10.1016/j.biochi.2011.02.003 Kramer, 2009, Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose, Ann. N. Y. Acad. Sci., 1171, 257, 10.1111/j.1749-6632.2009.04884.x Sun, 2002, The “French Paradox” and beyond: neuroprotective effects of polyphenols, Free Radic. Biol. Med., 32, 314, 10.1016/S0891-5849(01)00803-6 Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218 Alkhalaf, 2008, Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway, Arch. Med. Res., 39, 162, 10.1016/j.arcmed.2007.09.003 Alkhalaf, 2007, Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells, Pharmacology, 80, 134, 10.1159/000103253 Pozo-Guisado, 2005, Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB, Int. J. Cancer, 115, 74, 10.1002/ijc.20856 Tang, 2006, Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells, Mol. Cancer Ther., 5, 2034, 10.1158/1535-7163.MCT-06-0216 Hu, 2007, Antimyeloma effects of resveratrol through inhibition of angiogenesis, Chin. Med. J. (Engl), 120, 1672, 10.1097/00029330-200710010-00006 Ahmad, 2001, Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells, Clin. Cancer Res., 7, 1466 Heredia, 2000, Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol, J. Acquir. Immune Defic. Syndr., 25, 246, 10.1097/00126334-200011010-00006 Docherty, 1999, Resveratrol inhibition of herpes simplex virus replication, Antiviral Res., 43, 145, 10.1016/S0166-3542(99)00042-X Aggarwal, 2004, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer. Res., 24, 2783 Harikumar, 2008, Resveratrol: a multitargeted agent for age-associated chronic diseases, Cell Cycle, 7, 1020, 10.4161/cc.7.8.5740 Sexton, 2006, Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells, Mol. Cancer, 5, 45, 10.1186/1476-4598-5-45 Lin, 2008, Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells, J. Cell. Biochem., 104, 2131, 10.1002/jcb.21772 Lin, 2011, Inducible COX-2-dependent apoptosis in human ovarian cancer cells, Carcinogenesis, 32, 19, 10.1093/carcin/bgq212 Lin, 2011, Resveratrol and apoptosis, Ann. N. Y. Acad. Sci., 1215, 79, 10.1111/j.1749-6632.2010.05846.x Lee, 2000, Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells, Endocrinology, 141, 3764, 10.1210/endo.141.10.7697 Waas, 2002, Tissue levels of active matrix metalloproteinase-2 and −9 in colorectal cancer, Br. J. Cancer, 86, 1876, 10.1038/sj.bjc.6600366 Woo, 2004, Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction, Oncogene, 23, 1845, 10.1038/sj.onc.1207307 Toussaint-Smith, 2004, Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors, Oncogene, 23, 2988, 10.1038/sj.onc.1207442 Lopez-Ocejo, 2000, Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner, Oncogene, 19, 4611, 10.1038/sj.onc.1203817 Kim, 2006, Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt, Cell. Mol. Life Sci., 63, 930, 10.1007/s00018-005-5561-x Tang, 2007, Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells, Clin. Cancer Res., 13, 2568, 10.1158/1078-0432.CCR-06-2704 Hsu, 2009, Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells, Autophagy, 5, 451, 10.4161/auto.5.4.7666 Rezk, 2006, Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart, Am. J. Obstet. Gynecol., 194, e23, 10.1016/j.ajog.2005.11.030 Gupta, 2011, Chemosensitization of tumors by resveratrol, Ann. N. Y. Acad. Sci., 1215, 150, 10.1111/j.1749-6632.2010.05852.x Talwar, 2008 Ahn, 2003, Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions, Eur. J. Cancer Prev., 12, 383, 10.1097/00008469-200310000-00007 Vang, 2011, What is new for an old molecule? Systematic review and recommendations on the use of resveratrol, PLoS One, 6, e19881, 10.1371/journal.pone.0019881 Patel, 2011, Clinical trials of resveratrol, Ann. N. Y. Acad. Sci., 1215, 161, 10.1111/j.1749-6632.2010.05853.x Patel, 2010, Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients, Cancer Res., 70, 7392, 10.1158/0008-5472.CAN-10-2027 Brown, 2010, Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis, Cancer Res., 70, 9003, 10.1158/0008-5472.CAN-10-2364